Corrigendum to: "An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia"
- PMID: 40495616
- DOI: 10.2174/1871520625999250213162929
Corrigendum to: "An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia"
Abstract
The author has identified an error in the author's name in an article titled "An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia," published in Anti-Cancer Agents in Medicinal Chemistry, 2022, 18, 3050-3061 [1]. Details of the error and a correction are provided here. ORIGINAL: Andre Yohan1 1Department of Pharmaceutical Sciences, School of Pharmacy, MCPHS University, 19 Foster Street, Worcester, MA 01608, USA CORRECTED: Andre Yonan1 1Department of Pharmaceutical Sciences, School of Pharmacy, MCPHS University, 19 Foster Street, Worcester, MA 01608, USA We regret the error and apologize to readers. The original article can be found online at: https://www.benthamscience.com/article/122906.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Corrigendum to: Highly Efficient Bimetallic Catalyst for the Synthesis of N-substituted Decahydroacridine-1,8-diones and Xanthene-1,8-diones: Evaluation of their Biological Activity.Curr Org Synth. 2025;22(3):419. doi: 10.2174/1570179422999241118141411. Curr Org Synth. 2025. PMID: 40259594
-
Corrigendum to: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae Decoction.Curr Pharm Des. 2024 May 17;30(17):1377. doi: 10.2174/138161283017240501215827. Curr Pharm Des. 2024. PMID: 38975683
-
Corrigendum to: An Essential Role of c-Fos in Notch1-mediated Promotion of Proliferation of KSHV-Infected SH-SY5Y Cells.Curr Mol Pharmacol. 2024;17:e051124236081. doi: 10.2174/187446721701241105144436. Curr Mol Pharmacol. 2024. PMID: 40492553
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Corrigendum: N-unsubstituted Imidazoles: Design, Synthesis, and Antimicrobial Evaluation.Curr Pharm Des. 2024;30(15):1209. doi: 10.2174/138161283015240420013314. Curr Pharm Des. 2024. PMID: 38934466 Review.
References
-
- Yonan A.; Jacques C.; Fletcher T.; Suk-In T.; Campbell R.B.; An overview of conventional drugs and nanotherapeutic options for the treatment and management of pediatric acute lymphoblastic leukemia. Anticancer Agents Med Chem 2022,22(18),3050-3061